The invention discloses a preparation method of 6-aminocaproic acid which is a hemostatic.
本发明公开了一种止血剂6-氨基己酸的制备方法。
Results A total of 1343 patients (13.2%) received aprotinin, 6776 patients (66.8%) received aminocaproic acid, and 2029 patients (20.0%) received no antifibrinolytic therapy.
结果：1343例患者（13.2％）应用了抑肽酶，6776例患者（66.8％）接受了6-氨基已酸，2029例患者（20.0％）未接受抗纤维蛋白溶解治疗。
Results A total of 1343 patients (13.2%) received aprotinin, 6776 patients (66.8%) received aminocaproic acid, and 2029 patients (20.0%) received no antifibrinolytic therapy.
结果：1343例患者（13.2％）应用了抑肽酶，6776例患者（66.8％）接受了6-氨基已酸，2029例患者（20.0％）未接受抗纤维蛋白溶解治疗。
应用推荐